CUREMARK
Curemark is a biopharmaceutical company that focuses on the development of novel therapies to treat serious diseases for which there are limited treatment options for patients in need. It blends a unique business model with an expert team to bring promising medical technologies to patients. Their pipeline includes two Phase III clinical-stage programs for Autism and ADHD as well as three preclinical programs directed at Parkinson’s Disease, Schizophrenia, and Addiction. All of their product c... andidates address severe neurologic diseases that are currently believed to be underserved by available approved therapies and represent large potential commercial market opportunities. They believe that their product candidates offer innovative therapeutic approaches and may have the potential to provide significant advantages relative to current therapies.
CUREMARK
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2004-01-01
Address:
Rye, New York, United States
Country:
United States
Website Url:
http://www.curemark.com
Total Employee:
11+
Status:
Active
Contact:
(914) 925-3450
Email Addresses:
[email protected]
Total Funding:
74.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-14 | Curemark Announces the Promotion of Chiwon Yang to Vice President of Manufacturing Sciences and Technology |
Official Site Inspections
http://www.curemark.com
- Host name: 107.122.206.35.bc.googleusercontent.com
- IP address: 35.206.122.107
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Curemark"
Curemark - Biopharmaceutical Developments | Curemark
Founded in 2007, Curemark is a private, clinical-stage biopharmaceutical company developing novel therapies for the treatment of serious unmet needs in neuro-developmental and …See details»
About Us - Biopharmaceutical Company - Curemark
Dr. Matthew F. Heil has served as Curemark’s Chief Scientific Officer since 2008. Dr. Heil is responsible for the oversight and direction of all scientific programs as well as drug formulation and manufacturing. ... where she held operational …See details»
Management - Curemark
Curemark Management To develop breakthrough research and treatments, Curemark relies on the support of some of the strongest minds in the industry. Our management offers a wealth of experience from a medical, operational …See details»
Curemark - Crunchbase Company Profile & Funding
Curemark is a biopharmaceutical company that focuses on the development of novel therapies to treat serious diseases for which there are limited treatment options for patients in need. Their …See details»
Curemark, LLC - LinkedIn
Curemark, LLC | 2,782 followers on LinkedIn. From autism to ALS—redefining neurological care with science-driven, patient-focused therapies | Curemark is a clinical-stage biopharmaceutical ...See details»
Curemark 2025 Company Profile: Valuation, Funding & Investors
Curemark General Information Description. Operator of a clinical-stage biopharmaceutical company intended to focus on developing novel therapies for the treatment of neurological …See details»
Curemark - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 8, 2025 Curemark - Developer of therapeutics for the treatment of Autism and other neurological diseases. Raised a total funding of $96M over 13 rounds from 3 investors. …See details»
Curemark, LLC Company Profile | Rye Brook, NY - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Curemark, LLC of Rye Brook, NY. Get the latest business insights from Dun & Bradstreet.See details»
Curemark - Funding, Financials, Valuation & Investors - Crunchbase
Curemark is a socially-driven biotechnology company focusing on the treatment of autism and other neurological diseases. ... Experience the new Crunchbase, powered by AI . Experience …See details»
Curemark Company Profile - Office Locations, Competitors ... - Craft
Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. Its pipeline includes preclinical and clinical-stage programs …See details»
Curemark - Contacts, Employees, Board Members, Advisors
Curemark is a socially-driven biotechnology company focusing on the treatment of autism and other neurological diseases. ... Log In. Experience the new Crunchbase, powered by AI . …See details»
Curemark Profile - medical-xprt.com
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM …See details»
Our Values - Curemark
The reason why we come to work every day is simple: we are motivated first and foremost by our desire to understand and address the needs of patients and their families. Our core values …See details»
Meet The Woman Making Game-Changing Medicine A Reality
Oct 4, 2018 How did that work inspire Curemark? Fallon: I started seeing children in my office with autism in the late 1980’s early 1990’s. The incidence of autism has been growing in the …See details»
Curemark Company Information - Funding, Investors, and More
The company Curemark has raised a total of $25m in funding over 2 rounds. Key Insights: Curemark funding round, October 2013: $18.5m; Curemark Series A round: $6.5m; 2013. …See details»
Delving into the Latest Updates on Curemark LLC with Synapse
了解Curemark LLC (Curemark LLC)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 4篇新闻，疾病领域:神经系统疾病，内分泌与代谢疾病，技术平台:酶，药物:CM-AT，CM …See details»
Our Story - Biopharmaceutical Research - Curemark
Curemark has taken a different approach to research and development. Our approach is patient centered. Dr. Fallon’s Autism research began in the clinic, where she treated children, …See details»
Curemark - Overview, News & Similar companies | ZoomInfo.com
Curemark contact info: Phone number: (914) 824-9700 Website: www.curemark.com What does Curemark do? Galenagen is a wholly-owned subsidiary of Curemark, LLC, a clinical-stage …See details»
Curemark Autism: Promising Treatment Insights - NeuroLaunch.com
Aug 11, 2024 Curemark’s enzyme-based approach to autism treatment represents a promising development in the field of autism research and management. By focusing on a potential …See details»
Pipeline Archive - Curemark
Curemark has built a broad product pipeline that addresses an array of disorders. The company’s lead asset, CM-AT, is an orally-delivered treatment for Autism Spectrum Disorder (ASD). CM …See details»